Ionis Pharmaceuticals

Company

A San Diego-based company, formerly called ISIS, that developed a second-generation antisense oligonucleotide against the Lp(a) gene.

Mentioned in 1 video

Videos Mentioning Ionis Pharmaceuticals

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

Peter Attia MD

A San Diego-based company, formerly called ISIS, that developed a second-generation antisense oligonucleotide against the Lp(a) gene.